Axogen
IPOPeripheral Nerve Repair & Surgery Technologies
- Headquarters
- Alachua, Florida
- Employees
- 501–1000
- Founded
- 2002
- Business Model
- B2B
- Website
- axogeninc.com
- Total Funding
- $192.3M
- Last Round
- $124.0M Growth EquityJan 2026
- Rounds
- 5
- Type
- Public
About
Axogen, Inc. is a medical technology company founded in 2002 and headquartered in Alachua, Florida. It is the only company solely focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen's product portfolio includes the Avance Nerve Graft and Axoguard Nerve Connector and Protector devices, with clinical data showing sensory and motor recovery in 87% of patients. The company is publicly traded on Nasdaq (AXGN).
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jan 2026
Jan 2018
Jun 2012
Jan 2010
Jan 2008
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Outpatient mental health provider offering in-person and virtual therapy, psychiatry, and psychol...
Leading provider of diversified home and community-based health and pharmacy services to medicall...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...